These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 10966562)

  • 1. Subclassifying atypical urinary cytology specimens.
    Renshaw AA
    Cancer; 2000 Aug; 90(4):222-9. PubMed ID: 10966562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of atypical urine cytology in a tertiary care center.
    Deshpande V; McKee GT
    Cancer; 2005 Dec; 105(6):468-75. PubMed ID: 16080177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved correlation of urinary cytology specimens using The Paris System in biopsy-proven upper tract urothelial carcinomas.
    McIntire PJ; Snow JT; Robinson BD; Rao RA; Goyal A; Heymann JJ; Siddiqui MT
    Cancer Cytopathol; 2018 Jul; 126(7):498-504. PubMed ID: 29927548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between urinary cytology and pathology for nontransitional cell malignancies of the urinary tract.
    Raj GV; Bochner BH; Vickers A; Teper E; Lin O; Donat SM; Herr H; Dalbagni G
    J Urol; 2006 Jun; 175(6):2038-41; discussion 2041. PubMed ID: 16697796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Paris System for urine cytology in upper tract urothelial specimens: A comparative analysis with biopsy and surgical resection.
    Zheng X; Si Q; Du D; Harshan M; Zhang Z; Haines K; Shi W; Chhieng DC
    Cytopathology; 2018 Apr; 29(2):184-188. PubMed ID: 29251368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cytology in the detection and followup of urothelial tumors. Critical review of 500 cytologic investigations (authors transl)].
    Tostain J; Laurent JL; Pasteur X; Crochet J; Hugonnier G; Gilloz A
    J Urol (Paris); 1982; 88(2):91-6. PubMed ID: 7097029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Johns Hopkins Hospital template for urologic cytology samples: parts II and III: improving the predictability of indeterminate results in urinary cytologic samples: an outcomes and cytomorphologic study.
    VandenBussche CJ; Sathiyamoorthy S; Owens CL; Burroughs FH; Rosenthal DL; Guan H
    Cancer Cytopathol; 2013 Jan; 121(1):21-8. PubMed ID: 23192913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytologic diagnosis of low-grade papillary urothelial neoplasms (low malignant potential and low-grade carcinoma) in the context of the 1998 WHO/ISUP classification.
    Whisnant RE; Bastacky SI; Ohori NP
    Diagn Cytopathol; 2003 Apr; 28(4):186-90. PubMed ID: 12672093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The usefulness of urinary cytology testing in the evaluation of irritative voiding symptoms.
    Sokol ER; Patel SR; Clemons JL; Sung VW; Rardin CR; Myers DL
    Am J Obstet Gynecol; 2005 May; 192(5):1554-9. PubMed ID: 15902157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Urinary tumor marker for urothelial cancer].
    Ohtani M; Iwasaki A; Shiraiwa H
    Gan To Kagaku Ryoho; 2001 Nov; 28(12):1933-7. PubMed ID: 11729491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ProEx C as an adjunct marker to improve cytological detection of urothelial carcinoma in urinary specimens.
    Moatamed NA; Rao JY; Alexanian S; Cobarrubias M; Levin M; Lu D; Apple SK
    Cancer Cytopathol; 2013 Jun; 121(6):320-8. PubMed ID: 23364848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved diagnostic precision of urine cytology by implementation of The Paris System and the use of cell blocks.
    Chan E; Balassanian R; Tabatabai ZL; Lou H; Vohra P
    Cancer Cytopathol; 2018 Sep; 126(9):809-816. PubMed ID: 30203925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 20-year and 46,000-specimen journey to Paris reveals the influence of reporting systems and passive peer feedback on pathologist practice patterns.
    VandenBussche CJ; Allison DB; Gupta M; Ali SZ; Rosenthal DL
    Cancer Cytopathol; 2018 Jun; 126(6):381-389. PubMed ID: 29757495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between cytospin and liquid-based cytology in urine specimens classified according to the Paris System for Reporting Urinary Cytology.
    Straccia P; Bizzarro T; Fadda G; Pierconti F
    Cancer Cytopathol; 2016 Jul; 124(7):519-23. PubMed ID: 26989867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One year of experience using the Paris System for Reporting Urinary Cytology.
    Meilleroux J; Daniel G; Aziza J; d'Aure DM; Quintyn-Ranty ML; Basset CM; Evrard SM; Courtade-Saidi MM
    Cancer Cytopathol; 2018 Jun; 126(6):430-436. PubMed ID: 29663682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should the BK polyomavirus cytopathic effect be best classified as atypical or benign in urine cytology specimens?
    Allison DB; Olson MT; Lilo M; Zhang ML; Rosenthal DL; VandenBussche CJ
    Cancer Cytopathol; 2016 Jun; 124(6):436-42. PubMed ID: 26929126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved risk stratification for patients with high-grade urothelial carcinoma following application of the Paris System for Reporting Urinary Cytology.
    Cowan ML; Rosenthal DL; VandenBussche CJ
    Cancer Cytopathol; 2017 Jun; 125(6):427-434. PubMed ID: 28272842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma.
    Halling KC; King W; Sokolova IA; Meyer RG; Burkhardt HM; Halling AC; Cheville JC; Sebo TJ; Ramakumar S; Stewart CS; Pankratz S; O'Kane DJ; Seelig SA; Lieber MM; Jenkins RB
    J Urol; 2000 Nov; 164(5):1768-75. PubMed ID: 11025767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upper tract urothelial tumors. Diagnostic efficiency of radiology and urinary cytology.
    Boccon Gibod L; Chiche R; Dalian D; Steg A
    Eur Urol; 1982; 8(3):145-7. PubMed ID: 7075632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of fluorescence in situ hybridization as an ancillary tool to urine cytology in diagnosing urothelial carcinoma.
    Veeramachaneni R; Nordberg ML; Shi R; Herrera GA; Turbat-Herrera EA
    Diagn Cytopathol; 2003 Jun; 28(6):301-7. PubMed ID: 12768634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.